Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190

Watchlist Manager
Zylox-Tonbridge Medical Technology Co Ltd Logo
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Watchlist
Price: 15.9 HKD 2.45% Market Closed
Market Cap: 5.2B HKD

Zylox-Tonbridge Medical Technology Co Ltd
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zylox-Tonbridge Medical Technology Co Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Research & Development
-ÂĄ247.6m
CAGR 3-Years
-53%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Research & Development
-ÂĄ219.1m
CAGR 3-Years
-48%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Research & Development
-ÂĄ512.2m
CAGR 3-Years
-4%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Research & Development
-ÂĄ3.5B
CAGR 3-Years
-18%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Research & Development
-ÂĄ761.6m
CAGR 3-Years
5%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Research & Development
-ÂĄ1.7B
CAGR 3-Years
-32%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Zylox-Tonbridge Medical Technology Co Ltd
Glance View

Market Cap
5.2B HKD
Industry
Health Care

Zylox-Tonbridge Medical Technology Co., Ltd. operates as a medical devices company. The company is headquartered in Hangzhou, Zhejiang and currently employs 487 full-time employees. The company went IPO on 2021-07-05. The firm's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The firm's products are sold to domestic and foreign markets.

Intrinsic Value
19.22 HKD
Undervaluation 17%
Intrinsic Value
Price

See Also

What is Zylox-Tonbridge Medical Technology Co Ltd's Research & Development?
Research & Development
-247.6m CNY

Based on the financial report for Dec 31, 2023, Zylox-Tonbridge Medical Technology Co Ltd's Research & Development amounts to -247.6m CNY.

What is Zylox-Tonbridge Medical Technology Co Ltd's Research & Development growth rate?
Research & Development CAGR 3Y
-53%

Over the last year, the Research & Development growth was -11%. The average annual Research & Development growth rates for Zylox-Tonbridge Medical Technology Co Ltd have been -53% over the past three years .

Back to Top